Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
gimsilumab (1 trial)
Arthritis (Phase 1)
Arthritis, Rheumatoid (Phase 1)
Trials (1 total)
Trial APIs (1 total)